Dolby Laboratories (NYSE:DLB – Get Free Report) posted its quarterly earnings data on Thursday. The electronics maker reported $1.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.31 by $0.06, FiscalAI reports. Dolby Laboratories had a net margin of 17.97% and a return on equity of 11.50%. The firm had revenue of $395.63 million for the quarter, compared to the consensus estimate of $385.80 million. During the same period in the previous year, the firm earned $1.34 EPS. The business’s revenue for the quarter was up 7.0% compared to the same quarter last year. Dolby Laboratories updated its FY 2026 guidance to 4.300-4.450 EPS and its Q3 2026 guidance to 0.560-0.710 EPS.
Here are the key takeaways from Dolby Laboratories’ conference call:
- Q2 results met company guidance with $396M revenue and $1.37 non‑GAAP EPS; management reaffirmed full‑year guidance of $1.4B–$1.45B revenue and $4.30–$4.45 EPS while reporting $93M operating cash flow, a $65M buyback and ~$675M cash and investments.
- Broad content adoption is accelerating demand — major social platforms (Meta, Douyin), top music artists, marquee sports events (Super Bowl, Olympics, F1) and the top domestic films are streaming or produced in Dolby Atmos and Dolby Vision, supporting device and platform adoption.
- Automotive is a notable growth driver with wins from BMW, BYD (Denza), Lexus, NIO and Hyundai’s IONIQ (4‑channel Atmos), and the company says it is moving from premium to deeper, mass‑market vehicle lineups.
- New monetization initiatives — the Video Distribution patent pool now includes ~40 licensors and a growing licensee pipeline, and Dolby OptiView added customers (Genius Sports, William Hill) targeting personalized live sports experiences, but these programs are early in commercial ramp.
- Macro and product‑mix headwinds persist — memory pricing and timing affected mobile and PC (mobile down 6% this quarter), contributing to quarterly volatility even though management expects mid‑single‑digit full‑year growth in those end markets.
Dolby Laboratories Trading Up 1.5%
Shares of NYSE:DLB traded up $0.95 during midday trading on Thursday, reaching $64.21. The company had a trading volume of 646,070 shares, compared to its average volume of 476,438. The stock has a market cap of $6.13 billion, a P/E ratio of 25.89 and a beta of 0.86. The company’s 50 day moving average price is $62.58 and its 200 day moving average price is $64.55. Dolby Laboratories has a 52-week low of $57.62 and a 52-week high of $78.28.
Dolby Laboratories News Roundup
- Positive Sentiment: Q2 EPS and revenue beat consensus — Dolby reported GAAP/non‑GAAP beats (EPS $1.37 vs. est. $1.31) and revenue of ~$395.6M, reflecting year‑over‑year growth and better-than-expected top‑line. This supports near‑term earnings credibility. Zacks: Q2 Earnings and Revenues Top Estimates
- Positive Sentiment: Full‑year FY2026 EPS guidance raised above consensus — Dolby set FY26 EPS of $4.30–$4.45 versus a consensus near $4.11, which suggests stronger full‑year profitability even if near‑term quarters look soft. TipRanks: Posts Strong Q2 Results, Updates Outlook
- Neutral Sentiment: Revenue growth was modest — Q2 revenue rose ~7% YoY to ~$395.6M. Growth is positive but not accelerating sharply; investors will watch product adoption and licensing trends for follow‑through. QuiverQuant: Q2 Financials
- Neutral Sentiment: Street sentiment/targets remain constructive — a small number of recent analysts maintain buy/outperform stances and above‑current price targets, which can support the stock if guidance execution continues. QuiverQuant: Analyst Ratings & Targets
- Negative Sentiment: Near‑term guidance disappointed — Dolby lowered Q3 guidance to EPS $0.56–$0.71 (consensus ~$0.92) and revenue to $295–$325M (consensus ~ $343M), which pressures short‑term expectations and explains some sell pressure in after‑hours trading. Company Press Release / Guidance
- Negative Sentiment: Cash‑flow and metric nuances raise caution — third‑party reports note operating cash flow fell sharply YoY, some differences between GAAP and reported EPS metrics, and ongoing insider selling; these items raise longer‑term execution and capital‑allocation questions. QuiverQuant: Cash Flow & Insider Activity
Analyst Ratings Changes
A number of research firms recently weighed in on DLB. Rosenblatt Securities reissued a “buy” rating and set a $85.00 price target on shares of Dolby Laboratories in a research report on Friday, January 30th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Dolby Laboratories in a research note on Friday, March 27th. Barrington Research reissued an “outperform” rating and set a $90.00 target price on shares of Dolby Laboratories in a research report on Monday. Finally, Wall Street Zen downgraded Dolby Laboratories from a “buy” rating to a “hold” rating in a research note on Saturday, January 31st. Three analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, Dolby Laboratories currently has an average rating of “Moderate Buy” and an average target price of $90.75.
View Our Latest Stock Analysis on DLB
Insider Transactions at Dolby Laboratories
In other news, CAO Ryan Nicholson sold 2,667 shares of the stock in a transaction that occurred on Friday, February 13th. The shares were sold at an average price of $66.38, for a total transaction of $177,035.46. Following the completion of the transaction, the chief accounting officer directly owned 36,956 shares of the company’s stock, valued at $2,453,139.28. This represents a 6.73% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Shriram Revankar sold 3,000 shares of the firm’s stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $66.14, for a total transaction of $198,420.00. Following the sale, the senior vice president owned 83,218 shares of the company’s stock, valued at approximately $5,504,038.52. The trade was a 3.48% decrease in their position. The disclosure for this sale is available in the SEC filing. Company insiders own 37.93% of the company’s stock.
Hedge Funds Weigh In On Dolby Laboratories
Several institutional investors have recently bought and sold shares of DLB. AQR Capital Management LLC lifted its stake in Dolby Laboratories by 51.8% in the second quarter. AQR Capital Management LLC now owns 1,736,260 shares of the electronics maker’s stock valued at $128,935,000 after purchasing an additional 592,282 shares during the last quarter. Alyeska Investment Group L.P. purchased a new stake in Dolby Laboratories in the fourth quarter worth $23,477,000. First Trust Advisors LP raised its stake in shares of Dolby Laboratories by 23.8% in the fourth quarter. First Trust Advisors LP now owns 1,880,528 shares of the electronics maker’s stock valued at $120,768,000 after buying an additional 361,871 shares during the period. Voloridge Investment Management LLC raised its stake in shares of Dolby Laboratories by 2,017.9% in the fourth quarter. Voloridge Investment Management LLC now owns 325,499 shares of the electronics maker’s stock valued at $20,904,000 after buying an additional 310,130 shares during the period. Finally, Snyder Capital Management L P lifted its position in shares of Dolby Laboratories by 24.4% during the 4th quarter. Snyder Capital Management L P now owns 1,427,093 shares of the electronics maker’s stock valued at $91,648,000 after buying an additional 279,743 shares during the last quarter. Hedge funds and other institutional investors own 58.56% of the company’s stock.
About Dolby Laboratories
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
Read More
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
